NDC 0069-0188 – Ibrance
Palbociclib 100 mg/1 · Capsule · Oral
Product NDC0069-0188
Product details
- Brand name
- Ibrance
- Generic name
- Palbociclib
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA207103
- Marketed since
- February 3, 2015
- Marketing end
- July 31, 2029
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Palbociclib 100 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0069-0188-21 | 21 CAPSULE in 1 BOTTLE (0069-0188-21) | Feb 3, 2015 |
Other Ibrance products
- 0069-0187 Palbociclib 75 mg/1 · Capsule · Pfizer Laboratories Div Pfizer Inc
- 0069-0189 Palbociclib 125 mg/1 · Capsule · Pfizer Laboratories Div Pfizer Inc
- 0069-0284 Palbociclib 75 mg/1 · Tablet, Film Coated · Pfizer Laboratories Div Pfizer Inc
- 0069-0486 Palbociclib 100 mg/1 · Tablet, Film Coated · Pfizer Laboratories Div Pfizer Inc
- 0069-0688 Palbociclib 125 mg/1 · Tablet, Film Coated · Pfizer Laboratories Div Pfizer Inc
- 63539-284 Palbociclib 75 mg/1 · Tablet, Film Coated · U.S. Pharmaceuticals
- 63539-486 Palbociclib 100 mg/1 · Tablet, Film Coated · U.S. Pharmaceuticals
- 63539-688 Palbociclib 125 mg/1 · Tablet, Film Coated · U.S. Pharmaceuticals